Johnson & Johnson announced plans to invest more than $1 billion to build a next-generation cell-therapy manufacturing facility on a 154-acre site in Lower Gwynedd’s Spring House section. The project is expected to create about 4,000 construction jobs and 500 permanent skilled positions while expanding U.S. production of advanced treatments for cancer, immune-related and neurological diseases. The company already employs roughly 2,500 people locally, and officials, including Gov. Josh Shapiro, praised the investment as evidence of Pennsylvania’s growing strength in life-sciences manufacturing, workforce development and innovation. Supporters say the project will boost the regional economy and accelerate development of life-saving medicines.
Source: Around Ambler; 2/18/2026